← Back to headlines

AB Science adds new biomarker to Phase 3 masitinib ALS clinical trial

This story is reported by ALS News Today. Read what other outlets are saying below, then open the original report for full details.

AB Science adds new biomarker to Phase 3 masitinib ALS clinical trial · NabkaNews